Effect of obesity on short-and long-term mortality postcoronary revascularization: a meta-analysis. Objective: Overweight and obesity are often assumed to be risk factors for postprocedural mortality in patients with coronary artery disease (CAD). However, recent studies have described an "obesity paradox"-a neutral or beneficial association between obesity and mortality postcoronary revascularization. We reviewed the effect of overweight and obesity systematically on short-and long-term all-cause mortality post-coronary artery bypass grafting (CABG) and post-percutaneous coronary intervention (PCI).
Obesity is a highly and increasingly prevalent chronic condition associated with significant morbidity and mortality (1) . Overweight and obese individuals are at greater risk for developing coronary artery disease (CAD), primarily as a consequence of obesity-related conditions such as diabetes, hypertension, and dyslipidemia (2) . Accordingly, coronary revascularization is commonly performed in patients with increased BMI. Of the 197,105 isolated primary coronary artery bypass grafting (CABG) procedures performed nationally in the United States from 1997 to 2000, 31% were performed in moderately or severely obese individuals (BMI ≥ 35 kg/m 2 ) (3). Furthermore, in a large, population-based registry >95,000 angioplasty procedures in New York State, 43 and 24% of procedures were performed in overweight (BMI 25.0-29.9 kg/m 2 ) and obese individuals (BMI ≥ 30 kg/m 2 ), respectively (4) . It is likely that the number of obese and overweight individuals undergoing such procedures will increase substantially in the future.
Although the association between excess adiposity and cardiovascular risk in the general population has been well established (1) , the impact of overweight and obesity on mortality in patients with established CAD remains controversial and requires further investigation. Obesity is also often assumed to be a risk factor for postoperative morbidity/mortality following CABG and percutaneous coronary intervention (PCI) (5) because obesity predisposes toward chronic CAD, postprocedural wound complications (6), 30-day readmission (7) , and increased hospital length of stay (7) . However, recent studies have described an "obesity paradox" in patients undergoing PCI or CABG, reporting similar or lower postoperative mortality rates in obese patients compared to patients of normal weight (8) (9) (10) (11) . If valid, these provocative findings may have important clinical implications, as it can be legitimately questioned whether or not overweight or obese patients should be counseled to lose weight before a revascularization intervention. This systematic review was conducted to further explore the association between increased adiposity and postoperative all-cause mortality.
Methods search strategy
Detailed search strategies were designed with the help of a medical librarian to identify randomized controlled trials and observational studies evaluating the effect of overweight and obesity on postoperative mortality following PCI and CABG. A full search strategy is available were searched, reference lists of primary studies and review articles were reviewed, and three experts in the field were contacted. No language or age restrictions were applied.
Inclusion and exclusion criteria
Studies were required to separately report mortality in obese and normal weight patients using BMI categories. A priori, we knew that not all studies would use the traditional World Health Organization BMI classification system of 18.5-24.9, 25.0-29.9, and ≥30.0 kg/m 2 for normal, overweight, and obesity, respectively. Therefore, to avoid eliminating studies with important information we considered BMI levels within 2 kg/m 2 of standard categories to be acceptable. However, studies comparing obese and non-obese (i.e., normal and overweight patients grouped together) were excluded unless outcomes in the normal weight population alone could be ascertained. Articles were also excluded if the total number of deaths was <5, the citation was a review or duplicate article, and if the study was published only in abstract form.
outcomes
The primary outcome was all-cause mortality. As different factors may influence mortality in the immediate postoperative period vs. the long-term, we analyzed in-hospital/short-term (≤30 days) and longer term mortality separately. When studies reported mortality at two or more time intervals, the longest follow-up period was used for analysis. A priori, we planned a subgroup analysis examining the effect of moderate and/or severe obesity (BMI ≥ 35 kg/m 2 ) on mortality.
trial selection and data extraction One author (A.O.) pre-screened the search results to remove citations that were clearly not relevant. Two reviewers (A.O. and R.P.) independently reviewed the remaining citations and performed data extraction. Cohen's Kappa coefficients were calculated to assess inter-observer agreement for study inclusion and data extraction. Disagreements were resolved through consensus. Reviewers were not blinded to the authors' names and institutions, journal of publication, or study results. When necessary, additional data were requested from the primary study authors. Study quality was assessed using the Ottawa-New Castle Assessment Scale for observational studies (12) . data analysis PCI and CABG procedures were analyzed separately. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using RevMan ( version 4.2.8) using a random effects model. If obesity was subclassified as "mild, " "moderate, " and "severe, " results were collapsed into a single "obese" category for the primary analysis. Heterogeneity was examined using the Higgins I 2 test (13). Roughly, Higgins I 2 values of 25, 50, and 75% can be interpreted as indicating low, moderate, and high heterogeneity.
results
Of the 3,477 initial citations, 262 were potentially relevant upon initial screening, 49 were potentially appropriate for inclusion, and 22 met final inclusion criteria (Figure 1) . Interobserver agreement was 0.9 for study inclusion and 0.82 for data extraction.
No randomized controlled trials (RCTs) evaluating the effects of pre-revascularization weight change on postprocedural mortality were found. Ten post-PCI ( Table 1 ) and twelve post-CABG observational studies ( Table 2) were identified. Two studies reported results for both PCI and CABG as separate analyses within the same publication (9, 11) . Four publications represented the posthoc analyses of RCTs (8, 9, 11, 14) and the remainder were derived from primary cohorts.
Seventy percent of included studies were of high methodological quality (score 8-9/9) according to the Ottawa-New Castle criteria. Another 22% were of moderate methodological quality (score 6-7/9) and the remaining 8% were of low quality (score 4-5/9).
Main analysis
Post PCI. Five studies examined short-term/in-hospital mortality and eight studies reported long-term (1-5 year) mortality post-PCI (Figure 2) Post CABG. The effect of overweight and obesity on shortterm/in-hospital and long-term mortality post-CABG was assessed in eight studies (Figure 4) . Compared to individuals without elevated BMI levels, both overweight (OR 0.70; 95% CI 0.63-0.77) and obese (OR 0.63; 95% CI 0.56-0.71) patients had lower short-term/in-hospital mortality. In addition, moderately and/or severely obese patients were at lower risk of death (OR 0.66; 95% CI 0.51-0.86).
Five studies examined longer term outcomes, ranging from 1 to 5 years ( Figure 5 ). Overweight (OR 0.78; 95% CI 0.60-1.00) and obesity (OR 0.88; 95% CI 0.60-1.29) were associated with lower long-term mortality post-PCI. Moderate and/or severe obesity was associated with a neutral mortality risk (OR 1.42; 95% CI 0.76-2.65). There was no heterogeneity for the short-term/in-hospital mortality analyses, and heterogeneity was 47, 65, and 59% by Higgins I 2 for the overweight, obese, and moderate and/or severe comparisons for long-term mortality analyses, respectively.
sensitivity analysis
Owing to the possible confounding effects of including underweight patients in the studies which classified normal BMI as <25 kg/m 2 , a sensitivity analysis was conducted by excluding these studies ( Table 3) . The ORs and 95% CIs changed minimally in all analyses except the comparisons involving long-term mortality for moderately and/or severely obese individuals post-PCI and long-term mortality post-CABG. In the post-PCI sensitivity analysis, the CI for moderately and/or severely obese individuals changed to include one. In the post-CABG sensitivity analyses, obese patients were at significantly greater risk of death with long-term follow-up (Table 3) . However, this result must be interpreted with caution, as four out of a possible five studies were excluded because they classified normal BMI as <25 kg/m 2 . We found no evidence of a detrimental association between overweight or obesity and short-term or long-term mortality post-PCI and post-CABG. In fact, quantitative meta-analyses of the available literature suggests a potentially beneficial effect of elevated BMI levels on mortality in these populations. This protective effect is inconsistently attenuated with longer term follow-up periods, when the level of obesity has progressed into the moderate or severe range and when studies involving underweight patients are excluded from the analysis. Our results confirm the findings of a recently published meta-analysis examining the association between BMI and total mortality and cardiovascular events (15) . This review, which quantitatively combined results from long-term studies (>6 months) involving post-PCI, CABG, and myocardial infarction (MI) patients, found the highest risk of mortality with BMI levels <20 kg/m 2 and the lowest risk of mortality in overweight patients. Our results are similar, although we also included short-term/in-hospital mortality as an endpoint, did not include studies published as abstracts only, and felt that post-PCI and CABG populations were not similar enough to quantitatively combine into a single analysis. It is notable that combining these groups was associated with substantial statistic heterogeneity (15) .
In contrast to our results, one might expect excess body weight to be associated with an increased risk of death in patients postcoronary revascularization because of previously documented associations between obesity and other cardiovascular risk factors, cardiovascular disease, prothrombosis, inflammation, sympathetic nervous system activation, and mortality in the general population (2, 16, 17) . What, then, are the potential explanations for the "obesity paradox?" First, it is important to consider additional sources of bias. Obese patients consistently undergo revascularization procedures at a younger age than their non-obese counterparts and, consequently, may present with lower risk coronary anatomy (18) . On the other hand, the paradox may be due to selection bias if only a subgroup of the "healthiest" obese patients are surviving to revascularization or being selected for revascularization (19, 20) . In addition, concern that obese patients may Figure 4 30-Day/in-hospital mortality post-coronary artery bypass graft (CABG). ARTS, arterial revascularization therapy study; BARI, bypass angioplasty revascularization investigation; OR, odds ratio; OW, overweight.
Figure 5
Long-term mortality (1-5 years) post-coronary artery bypass graft (CABG). ARTS, arterial revascularization therapy study; BARI, bypass angioplasty revascularization investigation; OR, odds ratio; OW, overweight. (21) . Follow-up periods in studies to date may not be of sufficient length to demonstrate the expected negative impact of obesity on mortality. The confounding effects of smoking (which reduces body weight), the inclusion of underweight individuals, and unintentional weight loss due to (often unrecognized) chronic illness may increase mortality in patients with normal or underweight BMI categories (22) .
To explore the possibility of selection bias, we determined the relative frequencies of selected baseline covariates known to affect survival in the post-PCI or post-CABG populations ( Table 4) . Obese patients were younger, but had a higher prevalence of comorbidities such as hypertension, hypercholesterolemia, and diabetes mellitus. Other comorbidities such as history of MI, chronic heart failure, smoking history, unstable angina, and left main disease were similar or slightly less frequent in obese patients compared to those of normal weight. Even social class (education level) was similar between groups. Although such an analysis cannot be regarded as definitive because other measured or unmeasured confounders may be affecting survival, these data provide evidence that there are both favorable (age) and unfavorable risk factors are present in obese patients with CAD. It is notable that even after adjustment for baseline covariates, overweight or obesity do not seem to increase mortality in this patient population (15) .
Second, the possibility that the "obesity paradox" is a valid finding cannot be discounted. This paradox has been observed in a number of chronic disease states, including cancer, HIV infection, heart failure, rheumatic diseases, and end-stage renal failure (23) . Furthermore, in patients undergoing myocardial perfusion imaging for suspected coronary disease, obesity, and overweight were associated with a neutral effect on cardiac mortality in patients with negative scans and reduced mortality in patients with positive scans and, therefore, proven CAD (24) . Excess body weight may increase metabolic reserve and counteract the negative effects of chronic inflammation and cachexia (25, 26) . Specifically postrevascularization, obesity may improve outcomes because of larger vessel size and easier stent placement (27, 28) . Our results also suggest, albeit not definitively, that the potentially protective association between obesity and mortality is lost with longer follow-up periods and/or increasing severity of obesity. One may speculate that, with longer follow-up periods, the cumulatively detrimental effect of obesity on cardiovascular and metabolic (i.e., glycemic and lipid levels) function may manifest as increased mortality. In addition, severely obese individuals may have a higher risk of thrombosis (29) , inflammation (17), endothelial dysfunction (30) , under-dosing of anticoagulants (31), limited radiographic imaging of vessels, poor hemodynamic reserve (32) , and failed resuscitation (33) .
Several limitations of this meta-analysis should be noted. First, as with any systematic review, bias may occur due to selective study publication or if important studies were missed. We searched multiple databases and contacted content experts in an effort to minimize such bias. There were too few studies in each category to evaluate for potential publication bias using a funnel plot. However, publication bias tends to occur in the direction of non-neutral studies and, it is notable that no study found a positive association between obesity and mortality in overweight patients and only one study (9) found such an association in obese patients. Second, not all studies used the standard World Health Organization BMI classification system for body weight. In particular, several studies grouped normal and lower weight individuals together. As underweight (2), cachexia (34) , and malnutrition (25, 26) are associated with increased mortality, this may have resulted in an apparent relative benefit of overweight and obesity. However, our sensitivity analysis which excluded studies that classified <25 kg/m 2 as normal BMI (and thus included underweight patients in this category), demonstrated that this did not have any major effect on the results. Third, although BMI is the most commonly used epidemiologic measure of obesity, it is imperfect and does not directly distinguish between adipose and lean tissue or central and peripheral adiposity. We were unable to determine if the apparent protective effects of obesity are due to increased fat or lean body mass. Misclassification of body composition using BMI would be expected to bias our ORs toward the null, thereby potentially masking a non-neutral association between BMI and mortality. Fourth, moderate statistical heterogeneity was found when quantitative pooling was performed for some of our outcomes. This is not surprising, because there are many potential clinical and methodological explanations for heterogeneity in postrevascularization studies. These may include differences in procedural techniques, operator and center experience, contemporary and local practice patterns, postoperative care, and patient selection. We used a random effects model in an effort to incorporate heterogeneity between trials in our analysis, but recognize that this does not eliminate the fact that heterogeneity was present. Again, it is notable that nearly all studies reported a neutral or beneficial effect of elevated BMI levels on mortality, providing supportive evidence that the summary effect sizes were the product of consistent results. Finally, the observational nature of the studies identified provides associative, not causal, evidence, and mandates caution when interpreting the results.
conclusIons
In conclusion, observational studies suggest that obesity and overweight are associated with a neutral or beneficial effect on all-cause mortality postcoronary revascularization. This effect may be attenuated with longer follow-up periods and increasing severity of obesity. The underlying explanation for these results is unknown, although many potential explanations exist. Future prospective studies specifically designed to confirm or refute the "obesity paradox" and avoid potential bias inherent in previous research are required. Specifically, studies that more accurately quantify lean and fat tissue, central adiposity, temporal weight change, and intentionality of weight change should be performed. Until such data are available, the optimal weight-related treatment strategy for overweight and obese individuals postcoronary revascularization is unknown.
